It was something that I did not expect, considering Johnson & Johnson has been, which it is, since 1886. In mid-November, Johnson & Johnson announced that they would be splitting the business into two separate businesses. Big Changes Beginning With Splitting The Company Into Two Separate Businesses So, as you can see, the company is excited to turn the page and get onto 2022.
These are just two examples, but both of these situations gave Johnson & Johnson, which has spent decades building one of the strongest reputations, a bit of a black eye in the reputation department for this gold standard of a company. JNJ once again appealed and things were taken to the Supreme Court, as they sought to undo $2.1 billion penalty against them, but the high court rejected the appeal noting they would not hear the case. The company was originally hit with a $4.7 billion lawsuit that was awarded to nearly two dozen women who claimed the powder had asbestos that contributed to them contracting ovarian cancer.Īfter the original amount was awarded, Johnson & Johnson quickly appealed with the state of appeals, which dropped two of the women from the case and lowered the amount to $2.1 billion. The company also received a lot of negative press from its talc powder lawsuit that they have been trying to appeal over the years. The company had a COVID-19 vaccine that received a lot of negative press, but it continues to bring in money from that.
Johnson & Johnson ( NYSE: JNJ) has had a less than stellar year in 2021 and like many of us, they are looking to turn the page onto the year 2022. Yujie chen/iStock Editorial via Getty Images
0 kommentar(er)
